The reporter learned from the Suzhou Medical Research Institute of the Chinese Academy of Sciences that the team led by researcher Wang Daming has recently developed a rapid detection system for COVID-19 viral nucleic acid. This system can be stored and transported at room temperature, and qualitative results are produced in about 45 minutes. The instrument is small in size and easy to carry. It can perform on-site instant detection of COVID-19 viral nucleic acid.
According to reports, the average time for sample testing using the system is 45 minutes. In the detection, there is no need for nucleic acid extraction and purification, no PCR amplification, and the treatment solution directly lyses the pathogen and releases the target nucleic acid, thereby achieving qualitative judgment of the target nucleic acid in the sample. The kit can be stored and transported at room temperature, minimizing dependence on cold chain logistics. The technology performs well in terms of timeliness of sample testing, availability of technology platforms, convenience of testing and testing, and adaptability of reagents to the environment.
The matching kit developed for the COVID-19 virus has completed clinical trials of more than 600 samples, with an accuracy rate of more than 99%, and has been approved by the State Food and Drug Administration to obtain three types of medical device product registration certificates.